Monitoring of Bip promoter activation during cancer cell growth by bioluminescence imaging technique at single cell level by Horibe, Tomohisa et al.
Title
Monitoring of Bip promoter activation during cancer cell
growth by bioluminescence imaging technique at single cell
level
Author(s)
Horibe, Tomohisa; Torisawa, Aya; Kurihara, Ryohsuke;
Akiyoshi, Ryutaro; Hatta-Ohashi, Yoko; Suzuki, Hirobumi;
Kawakami, Koji




©2015Horibe T. This is an open-access article distributed
under the terms of the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction





Research Article ISSN: 2056-4546
Integrative Cancer Science and Therapeutics
Integr Cancer Sci Therap, 2015      doi: 10.15761/ICST.1000157  Volume 2(6): 291-299
Monitoring Bip promoter activation during cancer cell 
growth by bioluminescence imaging at the single-cell level
Tomohisa Horibe1, Aya Torisawa1, Ryohsuke Kurihara1, Ryutaro Akiyoshi2, Yoko Hatta-Ohashi2, Hirobumi Suzuki2 and Koji 
Kawakami1*
1Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan
2Research and Development Division, Olympus Corporation, 2-3 Kuboyama-cho, Hachioji-shi, Tokyo, Japan
Running title: Real-time monitoring by single-cell bioluminescence imaging
Abstract
Cancer cells require the regulation of organelle-specific unfolded protein responses, such as endoplasmic reticulum (ER) stress, because of their increased metabolic 
activity during rapid proliferation and cell growth, which are executed through the activation of diverse signaling pathways. In this study, we focused on the dynamic 
regulation of ER stress in accordance with cancer cellular demand, and we performed real-time monitoring of the activation of the binding immunoglobulin protein 
(Bip) promoter, which is one of the most responsive genes to ER stress during cancer cell growth, in two and three dimensional (2D and 3D) cell culture using 
bioluminescence imaging at the single-cell level. Bioluminescence images were obtained from living single cancer cells after transient transfection of the reporter gene, 
and we observed Bip promoter activation during cell growth. Bip promoter activation was also observed in 2D and 3D culture using stably transfected glioblastoma 
cancer cells with the reporter gene. The Bip promoter was activated especially in dividing cells during cell growth. We then performed real-time monitoring of 
Bip promoter activation by bioluminescence imaging in tissue slices obtained from U251/pBipPro-Luc tumors. Luminescence intensity was not constant and was 
different in individual regions of the tumor slices, and the Bip promoter was activated in several regions during monitoring in vitro. These results show that real-time 
monitoring by bioluminescence imaging at the single-cell level is a suitable tool for not only gene analysis of signal transduction and regulation of the dynamics of 
the unfolded protein response in cancer cells but also for the evaluation of the efficacy of anti-cancer agents, and could provide additional information that has been 
difficult to obtain using conventional assays. 
Abbreviations: ER: Endoplasmic Reticulum, 2D or 3D: Two or 
Three Dimensional, Bip/GRP78: Binding Immunoglobulin Protein/78 
kDa Glucose-Regulated Protein, LV200: LUMINOVIEW LV200, 
EGFR: Epidermal Growth Factor Receptor, Akt: Protein Kinase B, PBS: 
Phosphate-Buffered Saline, ROI: Region of Interest
Introduction
Eukaryotic cells contain a set of organelles that have specific cellular 
functions and respond to stress through the transcriptional activation 
of genes that regulate stress elements in their promoter regions. During 
organelle stress, the endoplasmic reticulum (ER) stress response (also 
known as the unfolded protein response), in which the accumulation 
of misfolded or unfolded proteins in the ER activates the ER-specific 
stress response, is currently one of the most well-elucidated organelle-
specific stress responses [1]. The ER, which occupies as much as 10% 
of total cell volume [2], is a significant and indispensable organelle for 
the folding and assembly of membrane or secreted proteins, lipid and 
sterol biosynthesis, and the storage of free calcium [3]. These newly 
synthesized membrane or secreted proteins correctly folded by ER 
chaperones and foldases, such as binding immunoglobulin protein (Bip; 
also known as 78 kDa glucose-regulated protein [GRP78]) and protein 
disulfide isomerase, in the ER are transported to the Golgi apparatus 
and then to the secretory pathway [4]. Bip is a major chaperone 
protein that is one of the most responsive proteins to ER stress, and 
has key roles as a pro-survival component in cells, such as protection 
from cell death and chemoresistance under ER stress conditions [5,6]. 
Many types of cancer reportedly rely on the ER to maintain the correct 
structure of important proteins in key signaling pathways [7]; in 
addition, a variety of cancers activate a group of signal transduction 
pathways upon ER stress to maintain ER homeostasis [8,9]. Elevated 
levels of Bip also reportedly protect against cancer cell death induced 
by several common anti-cancer drugs, such as doxorubicin, paclitaxel, 
and temozolomide [10-12]. Thus, the ER stress response in cancer cells 
is an important and attractive target not only to improve the efficacy 
of chemotherapy but also to lead to the development of novel types of 
anti-cancer agents.
Previously, we measured the activation of the Bip promoter under 
ER stress at the single-cell level using both high and low transfection 
efficiency cancer cells, and observed the activation of this promoter 
even in cells with the lowest transfection efficiency by single-cell 
bioluminescence imaging. We described how this system could be 
used for not only the rapid confirmation of transfection efficiency 
and the detection of reporter genes transiently transfected into several 
Correspondence to: Koji Kawakami MD, PhD, Department of 
Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto 
University, Yoshida Konoecho, Sakyoku, Kyoto 606-8501, Japan, Tel: +81-75-
753-4459, Fax: +81-75-753-4469; E-mail: kawakami.koji.4e@kyoto-u.ac.jp 
Key words: endoplasmic reticulum stress response, bioluminescence; single-cell 
level imaging, cancer cells, LV200 system
Received: October 04, 2015; Accepted: October 29, 2015; Published: November 
03, 2015
Horibe T (2015) Monitoring Bip promoter activation during cancer cell growth by bioluminescence imaging at the single-cell level
 Volume 2(6): 291-299Integr Cancer Sci Therap, 2015      doi: 10.15761/ICST.1000157
cancer and normal cell lines but also real-time monitoring of promoter 
activity using cancer cells that have low transfection efficiency [13]. 
Since bioluminescence imaging has several advantages, such as lower 
background and higher quantification [14], low levels of damage to 
living cells as the use of an excitation light is unnecessary [15], and 
longer observation periods (several days or weeks) [16], compared with 
fluorescence imaging, such as green fluorescent protein or fluorescein 
isothiocyanate. Real-time monitoring of ER stress by bioluminescence 
techniques during cancer cell growth would enable us to obtain novel 
information that is difficult to gain from conventional methods. 
In this study, we describe the real-time monitoring of Bip promoter 
activity based on bioluminescence imaging at the single-cell level during 
two and three dimensional (2D and 3D) cell culture. We also report the 
monitoring of Bip promoter activation in tissue slices obtained from 
U251 tumors, in which U251 cells were stably transfected with the 
reporter plasmid, by bioluminescence imaging in vitro. 
Materials and methods
Materials
Human breast adenocarcinoma cells (MDA-MB-231) and human 
fibrosarcoma cells (HT1080) were purchased from the American Type 
Culture Collection (Manassas, VA, USA). Human glioblastoma cell 
line (U251) was obtained as described previously [13]. The cells were 
cultured in RPMI-1640 (U251, HT1080, and MDA-MB-231) medium 
containing 10% fetal bovine serum, 100 μg/mL penicillin, and 100 μg/
mL streptomycin at 37°C in an atmosphere of 5% CO2/95% air. 
Cell growth assay
Cell growth was assessed using a WST-8 assay as described 
previously [17]. Briefly, the cells were seeded into 96-well plates at 3000 
cells/well, and then the number of living cells was measured by Living 
Cell Count Reagent SF (Nacalai Tesque, Kyoto, Japan) according to the 
manufacturer’s protocol. Absorbance was measured at a wavelength of 
450 nm using a 96-well microplate reader (GE Healthcare Bioscience, 
Piscataway, NJ, USA).
Construction of the reporter plasmid, transfection, and 
reporter assay 
The promoter region of Bip (-772 to +97) was amplified by PCR 
from human genomic DNA (Promega, Madison, WI, USA) based on 
the human genomic sequence information of NCBI using the following 
primers: 5′-GGGAGGGGACTCAGATCTGGAGGCAATTCCTTTG-
GC-3′ and 5′-CGGCAGGGGCCCGGGGTCACAAGCTTCCAC-
GAACCAGGC-3′ as the forward and reverse primers, respectively 
(mutated nucleotides to introduce BglII and HindIII restriction sites 
are underlined), and cloned into the BglII-HindIII sites of the pGL4.14 
vector (Promega), which contains the gene for firefly luciferase but 
lacks a eukaryotic promoter or enhancer elements. A reporter assay 
was carried out as described previously [18]. Briefly, the cells were 
transfected with the firefly luciferase-containing reporter plasmid con-
taining the Bip promoter (pBipPro-Luc) by Lipofectamine LTX (Invi-
trogen, Carlsbad, CA, USA) according to the manufacturer’s protocol. 
The Renilla luciferase-containing plasmid pRL-SV40 (Promega) was 
used as an internal control for reporter assays using a GloMax 96 mi-
croplate luminometer (Promega). The relative activity of firefly lucifer-
ase to Renilla luciferase was determined using the Dual-Glo Luciferase 
Assay System (Promega). ER stress was induced using thapsigargin as 
described previously [19]. 
Bioluminescence imaging
Bioluminescence images at the single-cell level were obtained using 
the LUMINOVIEW LV200 imaging system (Olympus, Tokyo, Japan) 
as described previously [13]. Briefly, after transient transfection with 
pBipPro-Luc, the culture dish was kept at 37°C in a humidified chamber. 
Images were taken using a 40× objective lens with 10- or 30-s exposures 
at 5- or 10-min intervals while observing Bip promoter activity after 
the addition of D-luciferin (Promega) at a final concentration of 500 
µM. Data analysis was performed using AQUACOSMOS software 
(ver. 2.6; Hamamatsu Photonics, Shizuoka, Japan). For the long-term 
observation of Bip promoter activation, U251 cells stably transfected 
with pBipPro-Luc (U251/pBipPro-Luc/stable cells) were prepared 
after transient transfection with Lipofectamine LTX according to the 
manufacturer’s protocol in a selective medium containing 200 μg/mL 
hygromycin B (Nacalai Tesque), and then bioluminescence images at 
the single-cell level were obtained using the LV200 system as described 
above. Bioluminescence images during 3D culture, in which a Cellbed 
sheet (Japan Vilene, Tokyo, Japan) was used, were obtained using the 
LV200 system with an ES10ZE focus controller (PRIOR Scientific, 
Rockland, MA, USA). Images of 5 µm thickness (total 100 µm) were 
taken using a 40× objective lens with a 10-s exposure at 10-min 
intervals. Data analysis was performed using cellSens Dimension (ver. 
1.9; Olympus) and Volocity 6.3 (PerkinElmer, Waltham, MA, USA) 
software. 
Bioluminescence imaging of Bip promoter activity in tissue 
slices from U251 tumors 
Animal experiment was carried out in accordance with the 
guidelines of the Animal Research Committee, Kyoto University. A 
suspension of U251/pBipPro-Luc/stable cells (1.0 × 107 cells/100 µL 
phosphate-buffered saline [PBS]) was transplanted subcutaneously into 
nude mice (female, 7-week-old BALB/c nu/nu mice; SLC, Shizuoka, 
Japan). When the average tumor volume reached approximately 150 
mm3, the luminescence intensity of each U251/pBipPro-Luc tumor 
was confirmed using an IVIS-200 in vivo imaging device (Xenogen, 
Alameda, CA, USA) after intraperitoneal injection with 100 µL 
D-luciferin (2 mg/mL), and then the tumor was harvested immediately 
after the mouse was sacrificed. Tissue slices (400-µm thick) from U251/
pBipPro-Luc tumors were prepared using a vibratome-type microslicer 
(LinearSlicer, Pro7; D.S.K, Kyoto, Japan) in ice-cold PBS according to 
the manufacturer’s protocol. Bioluminescence imaging of the tumor 
slices was performed using a 20× objective lens with a 10-s exposure at 
10-min intervals on a glass-bottom dish filled with RPMI medium after 
the addition of D-luciferin at a final concentration of 500 µM using the 
LV200 system. 
Results
Confirmation of the constructed Bip promoter reporter gene 
under ER stress in cancer cells
We first performed a cell growth assay to compare the growth 
rate among the U251, HT1080, and MDA-MB-231 cell lines, which 
were established from different kinds of cancer, but the transfection 
efficiency of reporter plasmid DNA in these cell lines is at a similar level 
[13]. As shown in Figure 1A, the growth rate among these cells was 
different: U251 cells were the most aggressive, while MDA-MB-231 
cells had the slowest growth rate among these cell lines under the same 
culture condition. When we examined the endogenous expression level 
of Bip protein in U251, HT1080, and MDA-MB-231 cells by western 
Horibe T (2015) Monitoring Bip promoter activation during cancer cell growth by bioluminescence imaging at the single-cell level
 Volume 2(6): 291-299Integr Cancer Sci Therap, 2015      doi: 10.15761/ICST.1000157
single-cell level using U251/pBipPro-Luc/stable cells, in which U251 
cells were stably transfected with the Bip promoter reporter gene, during 
cell growth. As shown in Figure 3, sufficient luminescence intensity for 
time course monitoring was observed in the U251/pBipPro-Luc/stable 
cells, and Bip promoter activation was also found at the single-cell 
level. Interestingly, the Bip promoter was activated periodically and the 
change of luminescence intensity occurred especially when the U251/
pBipPro-Luc/stable cells were dividing (Figure 3C). 
Time course analysis of Bip promoter activation in 
U251/pBipPro-Luc/stable cells during 3D cell culture by 
bioluminescence imaging at the single-cell level
Several recent reports showed that 3D cell culture is more 
physiologically relevant to cell morphology, gene and protein 
expression patterns, and cellular signaling compared with conventional 
2D monolayer cell culture [21-23]. Thus, we performed time course 
blotting, the expression level of Bip protein was not remarkably 
different among these cell lines (Supplementary Figure S1). We next 
performed a reporter assay using the Bip promoter reporter gene 
(pBipPro-Luc), which contains a cis-acting element in the promoter 
region that is regulated by ER stress [20], and examined the response of 
this construct in these cancer cell lines after the induction of ER stress 
by treatment with thapsigargin. It was confirmed that the constructed 
Bip reporter gene responded to ER stress in these cancer cell lines with 
different growth rates (Figure 1B). It was considered that the differences 
in growth rate among these cancer cells would not contribute to the 
response level of the Bip promoter following the induction of ER stress. 
Time course analysis of Bip promoter activation in cancer 
cells by bioluminescence imaging at the single-cell level
We performed time course analysis at the single-cell level using 
the LV200 system to capture bioluminescence images during cancer 
cell growth (U251, HT1080, and MDA-MB-231) after transient 
transfection with the Bip reporter gene. Real-time monitoring was 
also carried out during the growth of these cells. As shown in Figure 
2, sufficient luminescence intensity for time course monitoring was 
observed, and Bip promoter activation was also observed in all lines 
tested at the single-cell level during growth, although the intensity of 
the reporter gene was different between the cell lines. The Bip promoter 
was activated constantly in each examined cell line during growth, 
and its activation levels were not significantly different between the 
U251, HT1080, and MDA-MB-231 cells (Figure 2). It is suggested that 
the activation of the Bip promoter was significant during cancer cell 
growth, regardless of the different growth rates of these cell lines, and 
that constant ER stress was induced as described previously [8,9].
Time course analysis of Bip promoter activation in U251/
pBipPro-Luc/stable cells
As shown in Figures 1 and 2, the luminescence intensity level of 
the Bip promoter in U251 cells was sufficiently high for time course 
observations and the growth rate of this cancer cell line was the most 
aggressive among those analyzed. We next performed time course 
analysis of Bip promoter activity for a longer time period (>24 h) at the 
Figure 1. Cell growth and reporter assay using the Bip promoter reporter gene that responds to ER stress
(A) Cell growth assay for U251, HT1080, and MDA-MB-231 cells. Cell growth was assessed using a WST-8 assay at the indicated times. (B) Reporter assay of Bip promoter activation after 
the induction of ER stress. U251, HT1080, and MDA-MB-231 cells were transiently transfected with pBipPro-Luc, and then the reporter assay was performed using a luminometer after the 
induction of ER stress by thapsigargin (0.5 µM). Data represent the mean ± standard deviation (SD) from triplicate determinations in 96-well plates. 
Supplementary Figure S1: Expression levels of Bip protein in U251, HT1080, and 
MDA-MB-231 cells
Total cell extracts from the indicated cell lines were examined for Bip protein expression by 
western blotting with an anti-Bip antibody. β-Actin was used as the loading control. Bands 
were visualized by chemiluminescence.
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analysis of Bip promoter activity using U251/pBipPro-Luc/stable cells 
during 3D cell growth. U251/pBipPro-Luc/stable cells were seeded 
on a Cellbed sheet (as shown in Supplementary Figure S2A), and 
then the growth of the cancer cells in the 3D culture was confirmed 
by fluorescence microscopy analysis using CellMask staining 
(Supplementary Figure S2B). As shown in Figure 4A, bioluminescence 
images of U251/pBipPro-Luc/stable cells in the 3D culture were also 
generated using the LV200 system. The luminescence intensity of 
U251/pBipPro-Luc/stable cells was also sufficiently high for real-time 
monitoring of Bip promoter activity. In addition, the Bip promoter 
was also activated periodically during 3D cell culture at five selected 
regions of interest (ROIs) in the 3D bioluminescence images (Figure 
4B and4 C). These results indicate that the Bip promoter was activated 
periodically during cancer cell growth and its activation occurred 
especially when the cells were dividing, similar to the results presented 
in Figure 3. 
Time course analysis of tissue slices obtained from U251/
pBipPro-Luc tumors by bioluminescence imaging
Since the Bip promoter was activated in the examined cancer cell 
lines during growth under both 2D and 3D culture conditions and 
that many types of cancers reportedly rely on the ER stress response to 
maintain ER homeostasis [7-9], we investigated Bip promoter activation 
in tumors by real-time monitoring based on bioluminescence. U251/
pBipPro-Luc/stable cells were successfully transplanted subcutaneously 
into nude mice. As shown in Figure 5A, bioluminescence images of 
U251/pBipPro-Luc tumors were obtained using the IVIS imaging 
system, and it was confirmed that the Bip promoter was activated in 
the established stable cell line. We next examined the luminescence 
intensity of tissue slices from U251/pBipPro-Luc tumors using the 
LV200 system. As shown in Figure 5B, luminescence intensity was not 
constant and appeared different in individual regions; especially, the 
intensity was higher in the exterior region of the tumor slices compared 
with the interior region. When we performed time course analysis of 
bioluminescence with ROIs selected from these different luminescence 
intensity areas in the tumor slices, the Bip promoter was observed to 
be activated in several regions (such as ROIs 2, 3, 4, and 7) during 
incubation in the cell culture medium at 37°C in an atmosphere of 5% 
CO2/95% air using the LV200 system. It was also observed that there 
were two apparent activation peaks (at approximately 2.5–3 and 5 
Figure 2. Time course analysis of Bip promoter activation in cancer cells with different growth rates by bioluminescence imaging at the single-cell level
(A) Bioluminescence images of U251, HT1080, and MDA-MB-231 cells transiently transfected with pBipPro-Luc obtained by the LV200 system at 0, 12, and 24 h during cell growth. The 
squares in the bioluminescence images indicate the regions of interest (ROIs), in which luminescence intensity was measured for time-lapse analysis at the single-cell level. All scale bars 
are 100 μm. (B) Time course analysis of Bip promoter activation in single-cell imaging. Time course analysis of Bip promoter activation in U251, HT1080, and MDA-MB-231 cells after 
transient transfection with pBipPro-Luc using the LV200 system.
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days, respectively) of the Bip promoter in the different regions (such 
as ROIs 5, 6, and 7) during incubation of the slices (Figure 5C). Real-
time monitoring of the tumor slices using bioluminescence imaging 
could be performed until 6 days (144 h), at least on glass-bottom dishes 
filled with culture medium after the addition of D-luciferin using the 
LV200 system (Figure 5C), and this was a sufficiently long period to 
monitor the activation of the promoter in tissue slices, although the 
overall luminescence intensity decreased gradually (Figure 5B and5C). 
These results indicate that real-time monitoring of tissue slices based 
on bioluminescence imaging would be a novel tool for not only the 
analysis of promoter activation in vivo but also the evaluation of the 
anti-tumor activity of anti-cancer agents, which would enable us to 
obtain novel and significant information since we can observe regions 
on tissue slices in more detail and for a longer period through real-time 
monitoring with the LV200 system compared with that of conventional 
methods. 
Discussion
The ER stress response is one of the most elucidated organelle-
specific stress responses in eukaryotic cells [1], and it is well known that 
the stress response is a significant key factor for cancer cells to maintain 
ER homeostasis during their rapid and aggressive growth [7-9]. In this 
study, we performed real-time monitoring of Bip promoter activity 
during cancer cell growth under 2D and 3D cell culture conditions 
using bioluminescence imaging techniques at the single-cell level. 
We successfully obtained bioluminescence images of Bip promoter 
Supplementary Figure S2: 3D culture of cancer cells using a Cellbed sheet
(A) Scanning electron microscopy pictures (left) of a Cellbed sheet, which consists of sterilized high purity silica fibers for 3D cell culture, were taken using a Tabletop Microscope 
TM3030 (Hitachi High-Technologies, Tokyo, Japan). The Cellbed sheet was placed into a plastic plate as shown in the middle picture, and a cell suspension in medium was seeded on 
the Cellbed sheet (right diagram). The next day after seeding, the sheet was turned upside down, transferred to a glass-bottom dish containing medium with D-luciferin (right diagram), 
and then bioluminescence imaging during 3D culture of the cancer cells was performed with the LV200 system. (B) Fluorescence staining of U251/pBipPro-Luc/stable cells after 3D 
culture. At 5 days of 3D culture of U251/pBipPro-Luc/stable cells in the Cellbed sheet, the sheet was stained with CellMask, which specifically stains the plasma membrane, fixed with 4% 
paraformaldehyde in PBS, and then fluorescence images were obtained using an FV1000 confocal laser scanning microscope (Olympus). Fluorescence images shown in red taken every 1 
µm (for a total of 55 µm thickness) were captured using a 20× objective lens, and then data analysis was performed by FluoView software (Olympus). The scale bar indicates 100 μm. (C) 
Expression levels of EGFR, Bip, and Akt protein after 2D and 3D culture. Cell extracts after 2D or 3D culture were examined for EGFR, Bip, and Akt expression by western blotting with 
the corresponding antibodies. β-Actin was used as the loading control, and the bands were visualized by chemiluminescence.
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Figure 3. Time course analysis of Bip promoter activation in U251/pBipPro-Luc/stable cells by single-cell level imaging
(A) Bioluminescence images of U251/pBipPro-Luc/stable cells obtained by the LV200 system at 0, 24, 48, and 72 h during cell growth. The squares in the bioluminescence images indicate 
the ROIs, in which luminescence intensity was measured for time-lapse analysis at the single-cell level. All scale bars are 100 μm. (B) Time course analysis of Bip promoter activation 
in single-cell imaging. Time course analysis of Bip promoter activation in U251/pBipPro-Luc/stable cells was performed using the LV200 system. (C) Activation of the Bip promoter in 
dividing cancer cells. The images were taken using a high magnification objective lens (100×) with a 2-min exposure while observing Bip promoter activity. The Roman numerals in the 
images and numbers below each image indicate the order of cell division and luminescence intensity of these cells at the single-cell level, respectively. All scale bars are 50 μm.
activation under these culture conditions by real-time monitoring 
with the LV200 system. Since elevated levels of Bip reportedly protect 
cancer cells from death induced by several anti-cancer drugs [10-12], it 
is suggested that real-time monitoring of Bip promoter activity during 
cancer cell growth is significant for not only the improvement of the 
efficacy of chemotherapy but also for the development of new anti-
cancer drugs. Although bioluminescence has the disadvantage that its 
luminescence intensity is lower than that of fluorescence, we reported 
previously the successful development of a new optical system for 
bioluminescence imaging at the single-cell level by the combination of 
a microscope and a conventional cooled charge coupled device camera 
[24]. In the present study, we demonstrated that this new LV200 
optical system enabled us to obtain sufficient luminescence intensity 
for real-time monitoring in not only transiently transfected cancer cells 
but also cancer cells stably transfected with a reporter gene for long-
term observations. 
Malignant gliomas are the most commonly diagnosed and lethal 
type of malignant adult primary brain tumor, and complete resection 
is very difficult despite significant improvements in the surgical 
treatment of these tumors [25]. It was reported previously that Bip is 
a novel target for the improvement of chemosensitivity in malignant 
gliomas, and that the combination of agents capable of suppressing Bip 
with conventional anti-cancer drugs, such as temozolomide, would be 
a novel approach to eliminate residual cancer cells after surgery and 
increase the effectiveness of chemotherapy for malignant gliomas [10]. 
In this study, the Bip promoter was shown to be activated periodically, 
especially in dividing cells, under 2D and 3D cell culture conditions 
during cancer cell growth by real-time monitoring at the single-cell level. 
This finding is supported by a previous report in which the synthesis 
levels of several chaperone proteins, such as Hsp70, were increased 
during mitosis, although the total rate of protein synthesis in cells is 
decreased during mitosis because of increased phosphorylation of 
elongation factor 2 [26,27], suggesting that the roles of these chaperone 
proteins are indispensable during this phase of the cell cycle. We also 
showed that luminescence intensity was higher in the exterior region 
of tumor slices than in the interior region. These results indicate that 
the Bip promoter is activated in vigorously growing tumor cells. Thus, 
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Figure 4. Time course analysis of Bip promoter activation in U251/pBipPro-Luc/stable cells during 3D culture by bioluminescence imaging at the single-cell level
(A) A 3D bioluminescence image of U251/pBipPro-Luc/stable cells at 12 h during 3D cell culture in a Cellbed sheet using the LV200 system. (B) Slice view images of U251/pBipPro-
Luc/stable cells at 24, 48, and 72 h during 3D cell culture. All scale bars are 250 μm. (C) Time course analysis of Bip promoter activation in ROIs, which includes several cells that were 
selected at random, during 3D cell culture. Time course analysis of Bip promoter activation in U251/pBipPro-Luc/stable cells was performed using the LV200 system. The inset indicates 
3D bioluminescence images used for time-lapse analysis at 24, 48, and 72 h during 3D cell culture, and the squares in the images indicate the ROIs, in which luminescence intensity was 
measured for time-lapse analysis. All data from the 3D images were analyzed by cellSens Dimension or Volocity 6.3 software.
it is suggested that the real-time monitoring of Bip promoter activity by 
bioluminescence shown in this study would be a novel approach for the 
identification of effective chemotherapy regimens or the development 
of novel anti-cancer drugs for malignant gliomas. 
In this study we used a Cellbed sheet, which consists of sterilized 
high purity silica fibers and has a suitable structure for cancer cells 
to grow in 3D in culture medium as shown in Supplementary Figure 
S2A. The method using this sheet is easy and convenient for 3D cell 
culture compared with that of using a laminin-rich extracellular 
matrix, such as Matrigel [22,23]. Luca et al. recently reported that the 
3D microenvironment of cancer cells decreased the expression levels 
of epidermal growth factor receptor (EGFR) and that the pattern 
of gene expression was clearly altered in 3D cell culture compared 
with 2D culture [23]. As shown in Supplementary Figure S2C, the 
expression levels of several proteins such as EGFR and protein kinase 
B (Akt) were also changed after 3D cell culture using the Cellbed sheet 
compared with 2D culture. It is suggested that the culture condition 
of this sheet is different from the 2D monolayer condition and might 
supply a similar 3D microenvironment with the conventional method 
described above, although further study of the microenvironment is 
needed to confirm this hypothesis. We also demonstrated that it was 
possible to perform time course analysis of Bip promoter activation 
during 3D cell culture using selected ROIs in 3D bioluminescence 
images, in which several cells were included. Thus, time course analysis 
using 3D bioluminescence images obtained from 3D cell culture might 
provide novel information that is difficult to obtain using imaging of 
conventional 2D cancer cell cultures.  
We also showed that bioluminescence imaging enabled us to 
monitor Bip promoter activity in tumor slices during incubation in 
culture medium using the LV200 system (Figure 5B,5C). However, 
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Figure 5. Bioluminescence imaging of U251/pBipPro-Luc tumors or tissue slices using the IVIS or LV200 system
(A)In vivobioluminescence imaging of a U251/pBipPro-Luc tumor-xenografted mouse. The bioluminescence image was obtained with the IVIS spectrum system at 10 min after the injection 
of D-luciferin. The arrow indicates the tumor region. (B) Bioluminescence images of a tissue slice obtained from a U251/pBipPro-Luc tumor were captured with the LV200 system at 0, 24, 
48, 72, 96, and 120 h after the preparation of the sample, and D-luciferin was added to the culture medium. The squares in the bioluminescence images indicate the ROIs in which luminescent 
intensity was measured for time-lapse analysis. All scale bars are 500 µm. (C) Time course analysis of Bip promoter activation in tissue slices of a U251/pBipPro-Luc tumor. Time course 
analysis was performed using the LV200 system.
when we performed real-time monitoring using tumor slices, overall 
luminescence intensity in the tumor slices decreased gradually (Figure 
5B,5C). It was reported previously that oxyluciferin is produced by the 
oxidation of D-luciferin in medium during incubation [28], and it is 
suggested that oxyluciferin could affect the intensity of luminescence 
in tumor slices during observation. Although several improvements 
are needed for real-time monitoring of tumor slices in culture medium 
by bioluminescence for a period longer than 6 days, this technique 
with the LV200 system has several advantages associated with the use 
bioluminescence, such as less damage to living cells, compared with 
fluorescence. Thus, we can obtain available information from real-time 
monitoring using bioluminescence imaging at the single-cell level, 
which is difficult to obtain with the conventional methods. Taken 
together with our previous report [13], time-lapse analysis based on 
bioluminescence imaging at the single-cell level shown in this study has 
several advantages compared with conventional fluorescence imaging or 
reporter assays with a luminometer and would generate further significant 
information or findings for the ER stress response in cancer cells. 
Conclusions
In summary, the present data describe how a single-cell level 
bioluminescence imaging system can be used for not only real-time 
monitoring of promoter activation in individual cells during 2D and 
3D cell culture but also real-time monitoring of tissue slices obtained 
from tumors in vitro. Thus, these observations will be useful for further 
studies of gene analysis, signal transduction, and regulation of the 
dynamics of each organelle and organelle-specific stress responses in 
cancer cells based on a reporter assay using bioluminescence both in 
vitro and in vivo. 
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Supplemental materials and methods
Materials
An anti-Bip mouse monoclonal antibody was purchased from 
R&D Systems (Minneapolis, MN, USA). Anti-EGFR, anti-Akt, and 
anti-Erk1/2 antibodies were purchased from Cell Signaling Technology 
(Danvers, MA, USA). An anti-β-actin antibody was purchased from 
Sigma (St. Louis, MO, USA). CellMask was purchased from Invitrogen 
(Carlsbad, CA, USA). 
Western blotting 
Western blotting was performed as described previously [1]. 
Briefly, total protein extracts were prepared from cells lysed with 
reporter lysis buffer (Promega, Madison, WI, USA), separated by SDS-
PAGE, and then transferred to a nitrocellulose membrane using the 
iBlot system (Invitrogen) according to the manufacturer’s protocol. 
Quenched membranes were probed with antibodies and analyzed 
using the enhanced reagent Chemi-Lumi One Super (Nacalai Tesque) 
with a LAS-3000 LuminoImage analyzer (Fujifilm, Tokyo, Japan).
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